Food and Drug Administration advisers will hold a key meeting next month to discuss the state of the pandemic and whether COVID vaccines need to be modified again to better limit the fast-changing virus.
The big picture: Health experts say the Jan. 26 meeting, announced on Friday, will sketch out a long-term strategy that responds to new strains and shifting threats.
Health systems and pharmacies are running out of antibiotics like amoxicillin and other commonly used drugs just as the worst flu season in more than a decade is colliding with RSV and a rebound of COVID cases.
Why it matters: It highlights the U.S. vulnerabilities, yet again, when it comes to its ability to supply some of the most basic health care products — even children's Motrin.
The Supreme Court decision overturning Roe v. Wade and the baby formula shortage overshadowed the COVID pandemic in generating interest among registered voters this year, per a Morning Consult analysis shared first with Axios.
Why it matters: Americans appeared ready to move on after two years of pandemic news and seized on other big health care story lines, Ricky Zipp, health data reporter at Morning Consult, told Axios.
